The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 19, 2021

Filed:

Dec. 17, 2015
Applicant:

Fundación Para LA Investigación Mèdica Aplicada, Pamplona, ES;

Inventors:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C12N 9/14 (2006.01); A61K 38/46 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0058 (2013.01); A61K 38/46 (2013.01); A61K 48/005 (2013.01); A61K 48/0066 (2013.01); C12N 9/14 (2013.01); C12N 15/86 (2013.01); C12Y 306/03 (2013.01); C12Y 306/03004 (2013.01); C12N 2750/14143 (2013.01); C12N 2750/14171 (2013.01); C12N 2800/22 (2013.01); C12N 2830/008 (2013.01); C12N 2830/85 (2013.01);
Abstract

The invention relates to nucleic acid constructs and gene therapy vectors that comprise an ATP7B variant for use in the treatment of conditions associated with a deficiency or dysfunction of Copper-transporting ATPase 2, and particularly of Wilson's disease. An AAV vector devised according to the invention significantly reduced urine Cu excretion, and liver Cu content in Wilson's disease mice treated with the vector, while ceruloplasmin activity was significantly restored. On the other hand, the administration of the vector resulted in the normalization of serum transaminases' levels and of liver histology, together with a marked reduction of the inflammatory infiltrate.


Find Patent Forward Citations

Loading…